Related Articles
Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment
Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
Progress of immune checkpoint therapy in the clinic (Review)
Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)